Evaxion Biotech Files 6-K, Incorporates by Reference
Ticker: EVAX · Form: 6-K · Filed: May 5, 2025 · CIK: 1828253
| Field | Detail |
|---|---|
| Company | Evaxion Biotech A/S (EVAX) |
| Form Type | 6-K |
| Filed Date | May 5, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: filing-update, registration-statement
Related Tickers: EVX
TL;DR
EVX files 6-K, standard update, nothing new for traders.
AI Summary
Evaxion Biotech A/S filed a Form 6-K on May 5, 2025, to report its activities for the month of May 2025. The company is incorporated in Denmark and its principal executive offices are located in Hoersholm. This filing is incorporated by reference into several of Evaxion's existing registration statements on Forms S-8 and F-3, as well as various Form F-1 filings.
Why It Matters
This filing serves as an update and incorporates previous disclosures into ongoing registration statements, which is standard procedure for companies with active securities offerings or employee stock plans.
Risk Assessment
Risk Level: low — This is a routine filing that incorporates previous disclosures and does not contain new material financial or operational information.
Key Players & Entities
- Evaxion Biotech A/S (company) — Registrant
- 001-39950 (dollar_amount) — Commission File Number
- 333-255064 (dollar_amount) — Form S-8 File Number
- 333-265132 (dollar_amount) — Form F-3 File Number
- 333-266050 (dollar_amount) — Form F-1 File Number
- 333-276505 (dollar_amount) — Form F-1 File Number
- 333-279153 (dollar_amount) — Form F-1 File Number
- 333-283304 (dollar_amount) — Form F-1 File Number
- 333-285778 (dollar_amount) — Form F-3 File Number
FAQ
What is the purpose of this Form 6-K filing by Evaxion Biotech A/S?
The Form 6-K is filed for the month of May 2025 and serves to incorporate by reference the report into Evaxion A/S's existing registration statements on various forms (S-8, F-3, F-1).
What is Evaxion Biotech A/S's commission file number?
Evaxion Biotech A/S's commission file number is 001-39950.
Where are Evaxion Biotech A/S's principal executive offices located?
Evaxion Biotech A/S's principal executive offices are located at Dr. Neergaards Vej 5f, DK-2970 Hoersholm, Denmark.
Which registration statements does this Form 6-K filing get incorporated into?
This filing is incorporated by reference into Evaxion A/S's registration statements on Form S-8 (File No. 333-255064), Form F-3 (File No. 333-265132), and multiple Form F-1 filings (File Nos. 333-266050, 333-276505, 333-279153, 333-283304) and Form F-3 (File No. 333-285778).
Does Evaxion Biotech A/S file annual reports under Form 20-F or Form 40-F?
Evaxion Biotech A/S indicates that it files annual reports under cover of Form 20-F.
Filing Details
This Form 6-K (Form 6-K) was filed with the SEC on May 5, 2025 regarding Evaxion Biotech A/S (EVAX).